Clik here to view.
R-Tech Ueno: Termination of License Agreements for Unoprostone
TOKYO R-Tech Ueno (JASDAQ: 4573) R-Tech Ueno, Ltd. (RTU) today announced it has signed a termination agreement with Sucampo AG (SAG), one of the subsidiaries of Sucampo Pharmaceuticals, Inc....
View ArticleClik here to view.
ファインデックス、トライフォーの全事業を譲受
愛媛県松山市 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649、本社：愛媛県松山市三番町4-9-6、代表取締役社長：相原輝夫、以下ファインデックス）は、株式会社トライフォー（本社：東京都中野区中野5-68-2、代表取締役社長：広瀬...
View ArticleClik here to view.
Learn About the Latest Forensic DNA Technologies and Techniques at the 2015...
MADISON, Wis. The continued growth of DNA-typing technologies has technical, legal and ethical implications. Forensic professionals interested in learning about developing forensic DNA tools and...
View ArticleClik here to view.
The 2nd meeting of the Bridging Biomedical Worlds series: “From Neural...
PARIS Neural circuits are central to our understanding of how the brain works. Promoting basic research into the form and function of neural circuits and the translation of this research into...
View ArticleClik here to view.
Hoya Reports Fourth Quarter Results; Achieves Record Annual Sales and Profit
TOKYO HOYA Corporation (TOKYO: 7741) today announced financial results for the fourth quarter and full-year ended March 31, 2015. During the quarter, revenues increased by 10.6% to 127,440 million...
View ArticleClik here to view.
pSivida Announces Two Tech Evaluation Agreements with Leading Global...
WATERTOWN, Mass. pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in developing sustained release, drug delivery products for treating eye diseases, today announced that it has signed two funded...
View ArticleClik here to view.
武田宣布Ixazomib维持治疗用于新诊断多发性骨髓瘤的全球3期研究入组首例患者
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，评估研究中的口服新药ixazomib的3期TOURMALINE-MM4研究已入组首例患者。该项优效性研究旨在展示口服给药的蛋白酶体持续抑制能否改善多发性骨髓瘤患者的远期临床转归。...
View ArticleClik here to view.
GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its...
FLAGSTAFF, Ariz. W. L. Gore & Associates (Gore) today announced the GORE® EXCLUDER® Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and...
View ArticleClik here to view.
BeiGene Secures 600 Million RMB ($97 Million US) Financing
GRAND CAYMAN BeiGene Ltd., an innovative oncology company focused on developing targeted and immuno-oncology therapeutics, today announced the successful completion of a $US 97 million financing....
View ArticleClik here to view.
EOS imaging Expands Presence in Asia with First Installation in Hong Kong
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that the Department of Orthopaedics and Traumatology at the Chinese...
View ArticleClik here to view.
Acucela Announces Publication of Pre-clinical Data for Emixustat Hydrochloride
SEATTLE Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Nanova™ Therapy System Now Available from Acelity
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced that Nanova™ Therapy System, a new absorbent dressing enhanced with negative pressure for slow-to-heal...
View ArticleClik here to view.
Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement...
GOTEBORG, Sweden & TREVOSE, Pa. & VICTORIA, Australia Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases,...
View ArticleClik here to view.
OMT Therapeutics Announces UniRat™ Alliance with Caltech
PALO ALTO, Calif. OMT Therapeutics, Inc. (OMT Therapeutics) today announced a partnership with the California Institute of Technology (Caltech) under which Caltech will use OMT Therapeutics’ fully...
View ArticleClik here to view.
テラヴェクティスが米国遺伝子治療学会に参加し、研究開発および生産活動における最新の進捗状況を発表
パリ （ビジネスワイヤ） — パリに拠点を置く完全統合型の創薬・臨床開発企業としてレンチウイルスベクターを使用した治療用ワクチンとT細胞療法を専門とするテラヴェクティスは、ニューオーリンズで開催される第18回米国遺伝子治療学会（ASGCT）での4件のポスター発表により、2015年春・夏の活発な会議シーズンに乗り出します。ASGCTはこの種のカンファレンスとしては世界最大級のものです。...
View ArticleClik here to view.
MTTI receives expanded patent approval for 99mTc-Duramycin technology to...
WEST CHESTER, Pa. Molecular Targeting Technologies, Inc. (MTTI) announces today that the patent which it has exclusively licensed from the Medical College of Wisconsin (MCW), was granted by the...
View ArticleClik here to view.
R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent...
TOKYO R-Tech Ueno (JASDAQ:4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the...
View ArticleClik here to view.
Macrogen Enters Exome Sequencing Analysis Service Provision Agreement with...
SEOUL, South Korea The personalized medicine and biotechnology company, Macrogen (CEO Hyonyong Chong, www.macrogen.com) (KOSDAQ:038290) has announced that the company has entered into a genome...
View ArticleClik here to view.
SCIEX and the National University of Singapore Faculty of Science Sign a...
SINGAPORE SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences of the National University of...
View ArticleClik here to view.
S-BIO Launching BlotGlyco® O-Glycan Sample Preparation Kit in U.S., Japan
TOKYO Sumitomo Bakelite Co., Ltd. (TOKYO:4203) will launch “BlotGlyco® O-Glycan Sample Preparation Kit”, a breakthrough new product that enables scientists to analyze O-glycans in biological...
View Article